Matthias Bodenstedt
Chief Financial Officer · 5 filings · Latest: Jun 22, 2026
MoonLake Immunotherapeutics
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MLTX | Matthias Bodenstedt | Chief Financial Officer | Jun 22, 2026 | Sale | $22.04 | 39,120 | $862.2K | 1,115,435 | |
MLTX | Matthias Bodenstedt | Chief Financial Officer | Jun 18, 2026 | Sale | $19.60 | 2,794 | $54.8K | 1,154,555 | |
MLTX | Matthias Bodenstedt | Chief Financial Officer | Jun 17, 2026 | Sale | $19.68 | 15,082 | $296.8K | 1,157,349 | |
MLTX | Matthias Bodenstedt | Chief Financial Officer | May 11, 2026 | Sale | $20.02 | 13,653 | $273.3K | 1,172,431 | |
MLTX | Matthias Bodenstedt | Chief Financial Officer | Apr 14, 2026 | Sale | $19.56 | 2,426 | $47.5K | 1,186,084 | |
MLTX | Matthias Bodenstedt | Chief Financial Officer | Apr 10, 2026 | Sale | $19.51 | 1,925 | $37.6K | 1,188,510 | |
MLTX | Matthias Bodenstedt | Chief Financial Officer | Apr 9, 2026 | Sale | $18.94 | 85,870 | $1.6M | 1,190,435 | |
MLTX | Bodenstedt Matthias | — | Apr 9, 2026 | Proposed Sale | $18.46 | 160,870 | $3.0M | — |